Matthias Aizenberg

In a landscape where lung cancer remains one of the most challenging diseases to treat, particularly for rare subsets of patients, a new development has sparked hope among clinicians and affected individuals alike. Bayer’s recently approved drug, sevabertinib, marketed as Hyrnuo, has gained

The pharmaceutical landscape is on the brink of a seismic shift with the introduction of the FDA’s Commissioner’s National Priority Voucher (CNPV) pilot program, a bold initiative designed to cut the review timeline for drug and biological product applications from the standard 10-12 months down to

I'm thrilled to sit down with Ivan Kairatov, a renowned biopharma expert with a wealth of experience in research and development, as well as a keen understanding of technological innovation in the industry. Today, we’re diving into the recent developments surrounding Agios Pharmaceuticals and their

Imagine being told that a critical MRI scan, which takes just 15 minutes to complete, won’t be available for weeks, leaving a pressing health concern unanswered and anxiety mounting with each passing day. This frustrating scenario plays out for countless patients across hospital systems, where

In a world where cardiovascular diseases remain a leading cause of mortality, claiming millions of lives annually, a transformative shift is underway with the European Society of Cardiology (ESC) taking a bold step. The ESC has hosted its inaugural Digital & AI Summit in Berlin on November 21-22,

In the rapidly changing landscape of laboratory automation, a remarkable transformation is taking place that promises to redefine how scientific and diagnostic work is conducted, steering labs toward dynamic, collaborative environments. Mobile robots, infused with cutting-edge artificial

In a landscape where mental health crises are increasingly common, a troubling shift in New Zealand's support system has sparked alarm among professionals and advocates, highlighting significant safety concerns. The Public Service Association (PSA) Te Pūkenga Here Tikanga Mahi has voiced strong

I'm thrilled to sit down with Ivan Kairatov, a renowned biopharma expert with extensive experience in tech and innovation within the healthcare industry. Ivan has dedicated much of his career to advancing research and development, particularly in the intersection of technology and organ

In an era where global tensions and unexpected crises are becoming commonplace, the pharmaceutical industry faces unprecedented challenges in conducting clinical trials, which are essential for bringing life-saving drugs to market, and geopolitical instability—whether through armed conflicts like

The landscape of cancer care is undergoing a profound transformation with the advent of cutting-edge technologies that promise to redefine treatment precision and patient experience. At the forefront of this revolution stands the Huntsman Cancer Institute at the University of Utah, which has